Wang S - Search Results

1

A small molecule compound inhibits AKT pathway in ovarian cancer cell lines.

Tang HJ, Jin X, Wang S, Yang D, Cao Y, Chen J, Gossett DR, Lin J. Tang HJ, et al. Among authors: wang s. Gynecol Oncol. 2006 Feb;100(2):308-17. doi: 10.1016/j.ygyno.2005.08.044. Epub 2005 Oct 4. Gynecol Oncol. 2006. PMID: 16209885

2

Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells.

Zhang M, Liu H, Guo R, Ling Y, Wu X, Li B, Roller PP, Wang S, Yang D. Zhang M, et al. Among authors: wang s. Biochem Pharmacol. 2003 Jul 1;66(1):93-103. doi: 10.1016/s0006-2952(03)00248-x. Biochem Pharmacol. 2003. PMID: 12818369

3

Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists.

Wang S, Yang D, Lippman ME. Wang S, et al. Semin Oncol. 2003 Oct;30(5 Suppl 16):133-42. doi: 10.1053/j.seminoncol.2003.08.015. Semin Oncol. 2003. PMID: 14613034 Review.

4

Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.

Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, Lippman ME, Yang D, Wang S. Nikolovska-Coleska Z, et al. Among authors: wang s, wang r. J Med Chem. 2004 May 6;47(10):2430-40. doi: 10.1021/jm030420+. J Med Chem. 2004. PMID: 15115387

5

Design, synthesis, and evaluation of hexahydrobenz[f]isoquinolines as a novel class of dopamine 3 receptor ligands.

Wu X, Chen J, Ji M, Varady J, Levant B, Wang S. Wu X, et al. Among authors: wang s. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5813-6. doi: 10.1016/j.bmcl.2004.09.047. Bioorg Med Chem Lett. 2004. PMID: 15501046

6

Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2.

Real PJ, Cao Y, Wang R, Nikolovska-Coleska Z, Sanz-Ortiz J, Wang S, Fernandez-Luna JL. Real PJ, et al. Among authors: wang s, wang r. Cancer Res. 2004 Nov 1;64(21):7947-53. doi: 10.1158/0008-5472.CAN-04-0945. Cancer Res. 2004. PMID: 15520201

7

Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma.

Mohammad RM, Wang S, Aboukameel A, Chen B, Wu X, Chen J, Al-Katib A. Mohammad RM, et al. Among authors: wang s. Mol Cancer Ther. 2005 Jan;4(1):13-21. Mol Cancer Ther. 2005. PMID: 15657349

8

Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics.

Sun H, Nikolovska-Coleska Z, Chen J, Yang CY, Tomita Y, Pan H, Yoshioka Y, Krajewski K, Roller PP, Wang S. Sun H, et al. Among authors: wang s. Bioorg Med Chem Lett. 2005 Feb 1;15(3):793-7. doi: 10.1016/j.bmcl.2004.11.008. Bioorg Med Chem Lett. 2005. PMID: 15664859

9

(-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.

Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME. Xu L, et al. Among authors: wang s. Mol Cancer Ther. 2005 Feb;4(2):197-205. Mol Cancer Ther. 2005. PMID: 15713891

10

Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.

Ji M, Chen J, Ding K, Wu X, Varady J, Levant B, Wang S. Ji M, et al. Among authors: wang s. Bioorg Med Chem Lett. 2005 Mar 15;15(6):1701-5. doi: 10.1016/j.bmcl.2005.01.037. Bioorg Med Chem Lett. 2005. PMID: 15745825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117,233 results

Search Page

Filters